Correlation between ki-67 and telomerase expression with in situ hybridization for high-risk human papillomavirus

Archives of Biological Sciences

Volumn 65, Issue 1, 2013, Pages 81-90

  Vega Peña, Arianna ^a   Illades Aguiar, Berenice ^a   Flores Alfaro, Eugenia ^a   López Bayghen, Esther ^b   Reyes Maldonado, Elba ^c   Alarcón Romero, Luz Del Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b CINVESTAV DF   (Mexico)

^c INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Cervical intraepithelial neoplasia; Human papillomavirus; In situ hybridization; Ki 67; Telomerase

Indexed keywords

EID: 84873199494     PISSN: 03544664     EISSN: None     Source Type: Journal    
DOI: 10.2298/ABS1301081P     Document Type: Article

References (26)

1. Agoff, S.N., Lin, P., Morihara, J., Mao, C., Kiviat, N.B. and L.A. Koutsky. (2003) p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol. 16, 665-73.
2. Bahnassy, A.A., Zekri, A.R., Alam El-Din, H.M., Aboubakr, A.A., Kamel, K., El-Sabah, M.T. and N.M. Mokhtar. (2006) The role of cyclins and cyclin inhibitors in the multistep process of HPV-associated cervical carcinoma. J Egypt Natl Canc Inst. 18, 292-302.
3. Bellon, M. and C. Nicot. (2008) Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst. 100, 98-108.
4. Bravaccini, S., Sanchini, M.A., Amadori, A., Medri, L., Saragoni, L., Calistri, D., Monti, F., Volpi, A. and D. Amadori. (2005) Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J Clin Pathol. 58, 911-4.
5. Cheung, A.N., Chiu, P.M., Tsun, K.L., Khoo, U.S., Leung, B.S. and H.Y. Ngan. (2004) Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology. J Clin Pathol. 57, 721-7.
6. Cooper, K., Evans, M. and S. Mount. (2003) Biology and evolution of cervical squamous intraepithelial lesions: a hypothesis with diagnostic prognostic implications. Adv Anat Pathol. 10, 200-3.
7. Cooper, K., Herrington, C.S., Stickland, J.E., Evans, M.F. and J.O. McGee. (1991) Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation. J Clin Pathol. 44, 990-6.
8. Doorbar, J. (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci. (Lond). 110, 525-41.
9. Evans, M.F. and K. Cooper. (2004) Human papillomavirus integration: detection by in situ hybridization and potential clinical application. J Pathol. 202, 1-4.
10. Frost, M., Bobak, J.B., Gianani, R., Kim, N., Weinrich, S., Spalding, D.C., Cass, L.G., Thompson, L.C., Enomoto, T., Uribe-Lopez, D. and K.R. Shroyer. (2000) Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol. 114, 726-34.
11. Heatley, M.K. (2002) How should we grade CIN? Histopathology. 40, 377-90.
12. Illades-Aguiar, B., Alarcon-Romero, L.C., Antonio-Vejar, V., Zamudio-Lopez, N., Sales-Linares, N., Flores-Alfaro, E., Fernandez-Tilapa, G., Vences-Velazquez, A., Muñoz-Valle, J.F. and M.A. Leyva-Vazquez. (2010) Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol. 117;(2):291-6.
13. Kalof, A.N. and K. Cooper. (2006) p16INK4a immunoexpression: surrogate marker of high-risk HPV and high-grade cervical intraepithelial neoplasia. Adv Anat Pathol. 13, 190-4.
14. Kalof, A.N., Evans, M.F., Simmons-Arnold, L., Beatty, B.G. and K. Cooper. (2005) p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia. Am J Surg Pathol. 29, 674-9.
15. Keating, J.T., Ince, T. and C.P. Crum. (2001) Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol. 8, 83-92.
16. Kruse, A.J., Baak, J.P., de Bruin, P.C., Jiwa, M., Snijders, W.P., Boodt, P.J., Fons, G., Houben, P.W. and H.S. The. (2001) Ki-67 immunoquantitation in cervical intraepithelial neoplasia. (CIN): a sensitive marker for grading. J Pathol. 193, 48-54.
17. Liu, X., Dakic, A., Chen, R., Disbrow, G.L., Zhang, Y., Dai, Y. and R. Schlegel. (2008) Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc. J Virol. 82, 11568-76.
18. Mittal, K.R., Demopoulos, R.I. and S. Goswami. (1993) Proliferating cell nuclear antigen. (cyclin) expression in normal and abnormal cervical squamous epithelia. Am J Surg Pathol. 17, 117-22.
19. Munger, K., Baldwin, A., Edwards, K.M., Hayakawa, H., Nguyen, C.L., Owens, M., Grace, M. and K. Huh. (2004) Mechanisms of human papillomavirus-induced oncogenesis. J Virol. 78, 11451-60.
20. Nowak, J.A. (2000) Telomerase, cervical cancer, and human papillomavirus. Clin Lab Med. 20, 369-82.
21. Pirog, E.C., Isacson, C., Szabolcs, M.J., Kleter, B., Quint, W. and R.M. Richart. (2002) Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol. 21, 22-6.
22. Scholzen, T. and J. Gerdes. (2000) The Ki-67 protein: from the known and the unknown. J Cell Physiol. 182, 311-22.
23. Shay, J.W. and S. Bacchetti. (1997) A survey of telomerase activity in human cancer. Eur J Cancer. 33, 787-91.
24. Smith, D.L., Soria, J.C., Morat, L., Yang, Q., Sabatier, L., Liu, D.D., Nemr, R.A., Rashid, A. and J.N. Vauthey. (2004) Human telomerase reverse transcriptase. (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol. 11, 45-51.
25. Syrjanen, K.J. (2005) Immunohistochemistry in assessment of molecular pathogenesis of cervical carcinogenesis. Eur J Gynaecol Oncol. 26, 5-19.
26. Yang, J., Ramnath, N., Moysich, K.B., Asch, H.L., Swede, H., Alrawi, S.J., Huberman, J., Geradts, J., Brooks, J.S. and D. Tan. (2006) Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. BMC Cancer. 6, 203.